I think the jury is still deciding on this one In fact at AVA one MD agreed with the usage for those who had previous thrombosis and a high risk of thrombosis for cancer patients and that was the Italian Physician who was setting up country wide vascular access guidelines from the EVAN project.
Studies go both ways but a wise doctor said to be what does it hurt with a low dose for someone who is high risk? Kathy Confidentiality Notice: This e-mail and any attachments are intended only for the use of those to whom it is addressed and may contain information that is confidential and prohibited from further disclosure under law. If you have received this e-mail in error, its review, use, retention and/or distribution is strictly prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message and any attachments.[v1.0] -----Original Message----- From: [EMAIL PROTECTED] [mailto:[EMAIL PROTECTED] On Behalf Of [EMAIL PROTECTED] Sent: Wednesday, September 13, 2006 10:48 AM To: [EMAIL PROTECTED]; [EMAIL PROTECTED]; [EMAIL PROTECTED] Subject: Re: Portacath warfarin prophylaxis See Cancer Control Journal of the Moffitt Cancer Center. Vol. 12, September 2005., Supplement 1 "Venous Thromboembolism and Cancer:Current Issues and Treatment Directions" www.MoffittCancerCenter.org/ccjournal page 34 question #7. -----Original Message----- From: [EMAIL PROTECTED] To: [EMAIL PROTECTED]; [EMAIL PROTECTED] Sent: Wed, 13 Sep 2006 9:30 AM Subject: Re: FW: Portacath warfarin prophylaxis This is a controversial issue. There are small studies in oncology patients that support its use and some that do not. There was a series of practice guidelines related to anticoagulants and thrombolytics published in Chest 2004 and they recommended against its use. My opinion of that piece was that they did not have a good understanding of the true clinical impact of catheter-related thrombosis. But that is the most recent thing I can recommend. Lynn At 8:24 AM -0700 9/13/06, Marilyn Patterson wrote: This question from an internal medicine doc. Has this recommendation changed? Does any one have any references I can forward to this MD? Thanks as always so much for all your valued input and expertise. Marilyn Patterson RN CRN, CRNI Port Angeles, WA -------- From: Mark Fischer Sent: Tuesday, September 12, 2006 3:41 PM To: Marilyn Patterson; Tami Spaeder Subject: Portacath warfarin prophylaxis Hi Marilyn or Tami Historically, pt's have taken warfarin 1mg/day for this.. Recently, I think I've heard this is no longer recommended, right ? Do you have a reference to support this ? Thanks mark -- Lynn Hadaway, M.Ed., RNC, CRNI Lynn Hadaway Associates, Inc. 126 Main Street, PO Box 10 Milner, GA 30257 http://www.hadawayassociates.com office 770-358-7861 ________________________________________________________________________ Check out the new AOL. Most comprehensive set of free safety and security tools, free access to millions of high-quality videos from across the web, free AOL Mail and more.
